Literature DB >> 10941862

Esophageal motor disturbances in progressive systemic sclerosis.

M A Henry1, M C Harbermann, O M Rocha.   

Abstract

Ten patients with progressive systemic sclerosis (PSS) and esophageal symptoms (group 1) and 10 control subjects were studied. Esophageal electromanometry using the intermittent pull-through technique and catheter perfusion with distilled water were performed in all patients and individuals. The variables studied were pressure amplitude in the lower esophageal sphincter (LES) (mmHg) and deglutition wave amplitude (mmHg at 5, 10 and 15 cm above LES). In PSS patients, the average LES pressure was 18.5 +/- 4.6 mmHg, and in control subjects it was 27 +/- 6.5 mmHg (p < 0.01). Deglutition wave amplitude at 5, 10 and 15 cm above LES was 13.2 +/- 7.5 mmHg, 12 +/- 3.7 mmHg and 15 +/- 3.3 mmHg, respectively, in PSS patients. In control subjects, it was 67.6 +/- 12.5 mmHg, 58.6 +/- 20.9 mmHg and 52.4 +/- 21.4 mmHg (p < 0.001). In PSS patients, the pressure amplitude in LES and in the body of the esophagus was lower than in control subjects. In PSS patients, esophageal manometry showed the absence of normal peristalsis.

Entities:  

Mesh:

Year:  1999        PMID: 10941862     DOI: 10.1046/j.1442-2050.1999.00005.x

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  5 in total

1.  Oesophageal manometry in early and definite systemic sclerosis.

Authors:  Paolo Airò; Domenico Della Casa; Elisabetta Danieli; Guido Missale; Roberto Cattaneo; Renzo Cestari
Journal:  Clin Rheumatol       Date:  2004-12-09       Impact factor: 2.980

Review 2.  Gastrointestinal involvement in systemic sclerosis: pathogenesis, assessment and treatment.

Authors:  Elizabeth R Volkmann; Zsuzsanna McMahan
Journal:  Curr Opin Rheumatol       Date:  2022-08-19       Impact factor: 4.941

3.  Gastroesophageal reflux disease and connective tissue disorders: pathophysiology and implications for treatment.

Authors:  Marco G Patti; Warren J Gasper; Piero M Fisichella; Ian Nipomnick; Francesco Palazzo
Journal:  J Gastrointest Surg       Date:  2008-09-03       Impact factor: 3.452

4.  Esophagectomy in scleroderma: report of a case.

Authors:  Erdal Yekeler; Nesrin Gürsan
Journal:  Case Rep Gastroenterol       Date:  2008-12-05

5.  Preliminary safety and efficacy profile of prucalopride in the treatment of systemic sclerosis (SSc)-related intestinal involvement: results from the open label cross-over PROGASS study.

Authors:  Barbara Vigone; Monica Caronni; Adriana Severino; Chiara Bellocchi; Anna Rita Baldassarri; Mirella Fraquelli; Gaia Montanelli; Alessandro Santaniello; Lorenzo Beretta
Journal:  Arthritis Res Ther       Date:  2017-06-20       Impact factor: 5.156

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.